Get started
Author

D. V. Dayangi Hemalika

Observed names: D. V. D. Hemalika, D.V. Dayangi Hemalika, D.V.D. Hemalika, DVD Hemalika, Dr. DVD Hemalika
ORCID: 0000-0003-0378-1685
Observed ORCID: 0000-0003-0378-1685
OpenAlex ID: A5047471950
Phospholipase enzymes as potential biomarker for SARS CoV-2 virus
2020 · D.V.D. Hemalika · International Journal of Scientific and Research Publications · 6
Anti-dengue effects of medicinal plants: A review
2020 · DVD Hemalika, UG Chandrika · International Journal of Herbal Medicine · 5
PDF
Secretory phospholipase A2 inhibitory activity in Tragia hispida: A novel and promising therapeutic agent for dengue fever
2025 · D.V. Dayangi Hemalika, U.G. Chandrika, et al. · Phytomedicine Plus · 1
Potential traditional medicinal plants for COVID-19 management in Sri Lanka: A review
2023 · Dr. DVD Hemalika, RLIA Ranathunga · Journal of Medicinal Plants Studies · 1
PDF
Pharmacological potential of Cyanthillium cinereum (L.) H.Rob (Vernonia Cinerea): Ethnomedicinal and experimental evidence: A review
2026 · K. A. A. U. Karunarathna, W. M. K. M. Ratnayake, et al. · Ceylon Journal of Science
PDF
Characterization of secretory phospholipase A2 inhibitory activity in Tragia hispida as potential therapeutic agent for treatment of dengue
2024 · D. V. Dayangi Hemalika, Udumalagala Chandrika, et al.
PDF
Characterization of secretory phospholipase A2 inhibitory activity in Tragia hispida as potential therapeutic agent for treatment of dengue
2022 · Gathsaurie N Malavige, D. V. Dayangi Hemalika, et al.
PDF
Characterization of secretory phospholipase A2 inhibitory activity in Tragia hispida as potential therapeutic agent for treatment of dengue
2022 · D. V. Dayangi Hemalika, U.G. Chandrika, et al. · medRxiv
PDF
Works count: 8
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type